secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longeveron Inc. (LGVN)
CIK:        0001721484
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001013762-23-003640
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longeveron announces $4M registered direct offering and private placement of common stock and warrants
--------------------------------------------------------------------------------

- Offering includes 2,424,243 shares of common stock at $1.65/share and pre-funded warrants for 59,243 shares.
- Concurrent private placement of unregistered Series A and Series B warrants to purchase up to 2,424,243 shares each.
- Net proceeds to fund clinical development of Lomecel-B™ and for working capital.
- Offering expected to close on October 13, 2023; H.C. Wainwright acted as placement agent.
- Warrants require stockholder approval before exercisable; Series A term 5.5 yrs, Series B 18 months.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1721484/000101376223003640/0001013762-23-003640-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1721484/000101376223003640/ea186688-8k_longeveron.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-003640

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer